Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma

NCT02462525 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

74

Enrollment

INDUSTRY

Sponsor class

Stopped No Go decision for ABBV-838

Conditions

Multiple Myeloma

Interventions

DRUG: ABBV-838
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

AbbVie